Wim H.J. Kruit
Erasmus MC Cancer Institute(NL)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses, CAR-T cell therapy research, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience(2006)906 cited
- → Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial(2008)642 cited
- → Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy(2013)473 cited
- → Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial(2005)314 cited
- → Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma(2012)281 cited
- → Side Effects of Interferon-α Therapy(2005)280 cited